BioWorld

Sep. 9, 2003

Axon Branches Of Young Mice Push Fast, Retract Within Minutes While Aging Synapses Get Stabler

Incyte's Evolution Continues As It Licenses Late-Stage HIV Drug

Genentech, XOMA Appear Poised For Favorable Word On Raptiva

Other News To Note

Regeneron, Aventis In Potential $485M Alliance On VEGF Trap

Regeneron Inc.'s fortunes - and its stock - experienced an upswing Monday with the disclosure of a potential $485 million deal focused on its VEGF Trap product candidate with Aventis SA. (BioWorld Today) Read More

Biovitrum Lands Blockbuster Deal With Amgen In Metabolics

Today's news in brief

BioWorld

BioWorld briefs for June 17, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

For clonal hematopoiesis, epigenetics can be in driver’s seat

BioWorld Science

Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...

Illustration of amyloid plaques in Alzheimer's disease

Elixiron’s enrupatinib shows upbeat interim phase II AD results

BioWorld

Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...

Viva in vivo! At EHA, in vivo CAR T data continues to impress

BioWorld

Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...